HOME >> BIOLOGY >> NEWS
UC San Francisco patents method for delivering normal genes in a pill

The first patent for a method of delivering normal genes in a pill to induce the production of insulin in people with diabetes was issued May 1 to the University of California, San Francisco by the United States Patent and Trademark Office.

Sometimes referred to as a "gene pill," the oral delivery of normal genes has been a long-sought and elusive technique. Now, UCSF researchers have successfully demonstrated that raw DNA taken orally can find its way inside cells lining the intestinal tract and prompt those cells to express a protein, such as insulin, even though they are not specialized for that purpose.

"Considerable work still needs to be done before there is an actual gene pill for insulin production, but the patent demonstrates the validity of the concept and promises to spur development of oral delivery of genes to treat a vast number of illnesses," said Stephen S. Rothman, PhD, professor of physiology in the UCSF Schools of Medicine and Dentistry.

The technique holds the potential for providing patients with more than 50 proteins normally secreted by the body into blood and which patients now receive by injection into muscles - including insulin, growth hormones, blood factors for treating hemophilia, and erythropoietin for treating anemia. Rothman expressed confidence that future patent awards to UCSF would cover development of the method for many illnesses.

Genteric, a biotechnology company in Alameda, Calif. has an exclusive, worldwide license agreement with the University to use the method for drug development. The inventors of the technique - Rothman; Michael S. German, MD, associate professor of medicine in the UCSF Hormone Research Institute; and Ira Goldfine, MD, UCSF professor of medicine - along with Michael H. Nantz, PhD, professor of chemistry at UC Davis, are the founders of Genteric.

The research team began studying the technique at UCSF five years ago with funding from the UCSF Foundation and
'"/>

Contact: Bill Gordon
bgordon@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
2-May-2001


Page: 1 2 3

Related biology news :

1. VIB presents its annual results at BIO2004 in San Francisco
2. Invasive cordgrass in San Francisco Bay
3. Life in ice scientist hopes for power in San Francisco
4. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students
5. Massive new research effort will map inner workings of cells - San Francisco VA Medical Center chosen to host core laboratory
6. A more accurate measure of exercise ability in older people reported by San Francisco VA Medical Center researchers
7. Futurist research highlights chemists national meeting March 26-30 in San Francisco
8. NASA Exhibit In San Francisco To Show How Space Research Improves Health Care On Earth
9. University Of California-San Francisco Researchers Report Test That Detects Prion Diseases, Illuminates Novel Findings About Infectious Prions
10. University Of California-San Francisco (UCSF) Translational Symposium, September 10, To Focus On HIV Breakthrough And Immune Function
11. HIV Patients Often Experience Viral "Breakthrough," But May Still Remain Healthy, San Francisco Study Finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 21, 2020 , ... ... technology-based services specializing in background and medical screening, announces the launch of ... and keeping their workforce safe. The new service is provided by ClearStar’s ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which takes ...
(Date:5/21/2020)... ... 21, 2020 , ... Agility Orthopedics, home to dedicated specialists ... is pleased to announce a partnership with Dallas-based Simple Interact to further enhance ... area, Agility Orthopedics is focused on speeding up patient workflows to enhance patient ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... ... multiple open heart surgeries before becoming adults. The reason: there are ... address this critical unmet need, the Department of Defense has awarded Draper, Boston ...
(Date:5/14/2020)... ... 2020 , ... DuPont Nutrition & Biosciences (N&B) has announced ... care ingredients in Russia and Belarus. Beginning May 1, Interdisp JCS will represent ... , The GENENCARE®OSMS product line contains a range of all-natural, 100 ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of drug discovery ... no information on the drug’s mechanism of action (MOA). Gene expression profiling technologies ... the activity of molecular pathways. This information can complement phenotypic readouts and can ...
(Date:5/5/2020)... ... May 05, 2020 , ... ProductLife Group has ... Xavier Duburcq joins the group after 13 years at Altran, where he was Group ... PhD in Immunology and being a Pharmacist, Xavier was involved in his early career ...
Breaking Biology Technology:
Cached News: